Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06985524Enrolling by invitation
Randomised, double-blind trial in functional dyspepsia (FD) comparing Weipi Formula with Placebo (2 arms). Primary endpoint: Traditional Chinese Medicine Syndrome Scores at 2 weeks. Started Jan 2024; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06985524.